Legal & General Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $111M | Buy |
186,794
+13,202
| +8% | +$6.57M | 0.03% | 489 |
|
|
2025
Q4 | $84.6M | Sell |
173,592
-26,064
| -13% | -$12.1M | 0.02% | 547 |
|
|
2025
Q3 | $83.7M | Buy |
199,656
+1,137
| +0.6% | +$382K | 0.02% | 549 |
|
|
2025
Q2 | $57M | Buy |
198,519
+8,149
| +4% | +$2.44M | 0.01% | 596 |
|
|
2025
Q1 | $58.7M | Buy |
190,370
+16,611
| +10% | +$5.69M | 0.02% | 589 |
|
|
2024
Q4 | $61.3M | Sell |
173,759
-9,029
| -5% | -$3.32M | 0.02% | 585 |
|
|
2024
Q3 | $65.5M | Sell |
182,788
-6,074
| -3% | -$2.05M | 0.02% | 593 |
|
|
2024
Q2 | $60.2M | Sell |
188,862
-14,167
| -7% | -$3.75M | 0.02% | 591 |
|
|
2024
Q1 | $46.6M | Sell |
203,029
-10,564
| -5% | -$2.38M | 0.01% | 646 |
|
|
2023
Q4 | $47M | Sell |
213,593
-6,010
| -3% | -$1.39M | 0.01% | 645 |
|
|
2023
Q3 | $49.6M | Sell |
219,603
-1,936
| -0.9% | -$446K | 0.02% | 632 |
|
|
2023
Q2 | $48.9M | Buy |
221,539
+4,764
| +2% | +$1.06M | 0.02% | 645 |
|
|
2023
Q1 | $48.5M | Buy |
216,775
+95,909
| +79% | +$23.6M | 0.02% | 630 |
|
|
2022
Q4 | $33.6M | Buy |
120,866
+5,813
| +5% | +$1.47M | 0.01% | 694 |
|
|
2022
Q3 | $24.1M | Sell |
115,053
-3,535
| -3% | -$790K | 0.01% | 756 |
|
|
2022
Q2 | $27.9M | Sell |
118,588
-1,774
| -1% | -$361K | 0.01% | 747 |
|
|
2022
Q1 | $21.6M | Buy |
120,362
+2,631
| +2% | +$501K | 0.01% | 859 |
|
|
2021
Q4 | $25.4M | Buy |
117,731
+3,144
| +3% | +$617K | 0.01% | 836 |
|
|
2021
Q3 | $21.2M | Buy |
114,587
+502
| +0.4% | +$98.9K | 0.01% | 872 |
|
|
2021
Q2 | $20.5M | Sell |
114,085
-15,470
| -12% | -$2.95M | 0.01% | 893 |
|
|
2021
Q1 | $21.7M | Sell |
129,555
-1,315
| -1% | -$219K | 0.01% | 856 |
|
|
2020
Q4 | $19.9M | Sell |
130,870
-6,736
| -5% | -$884K | 0.01% | 848 |
|
|
2020
Q3 | $13.9M | Buy |
137,606
+2,831
| +2% | +$311K | 0.01% | 894 |
|
|
2020
Q2 | $16.3M | Buy |
134,775
+9,805
| +8% | +$1.1M | 0.01% | 839 |
|
|
2020
Q1 | $11.8M | Sell |
124,970
-1,810
| -1% | -$172K | 0.01% | 858 |
|
|
2019
Q4 | $11.2M | Buy |
126,780
+5,018
| +4% | +$442K | 0.01% | 975 |
|
|
2019
Q3 | $9.71M | Buy |
121,762
+8,116
| +7% | +$654K | 0.01% | 991 |
|
|
2019
Q2 | $8.87M | Sell |
113,646
-50,413
| -31% | -$4.71M | ﹤0.01% | 1015 |
|
|
2019
Q1 | $19.3M | Buy |
164,059
+51,428
| +46% | +$5.99M | 0.01% | 761 |
|
|
2018
Q4 | $12.3M | Buy |
112,631
+11,664
| +12% | +$1.35M | 0.01% | 792 |
|
|
2018
Q3 | $12.9M | Buy |
100,967
+2,399
| +2% | +$297K | 0.01% | 809 |
|
|
2018
Q2 | $11.2M | Sell |
98,568
-330
| -0.3% | -$36.3K | 0.01% | 823 |
|
|
2018
Q1 | $11.1M | Buy |
98,898
+7,156
| +8% | +$909K | 0.01% | 802 |
|
|
2017
Q4 | $13.6M | Buy |
91,742
+1,896
| +2% | +$241K | 0.01% | 742 |
|
|
2017
Q3 | $10.5M | Buy |
89,846
+8,549
| +11% | +$1.09M | 0.01% | 768 |
|
|
2017
Q2 | $10.5M | Buy |
81,297
+9,664
| +13% | +$1.21M | 0.01% | 752 |
|
|
2017
Q1 | $9.7M | Buy |
71,633
+19,855
| +38% | +$3.01M | 0.01% | 756 |
|
|
2016
Q4 | $7.43M | Buy |
51,778
+7,806
| +18% | +$997K | 0.01% | 788 |
|
|
2016
Q3 | $5.19M | Buy |
43,972
+2,726
| +7% | +$328K | 0.01% | 776 |
|
|
2016
Q2 | $4.37M | Buy |
41,246
+9,331
| +29% | +$1.04M | ﹤0.01% | 783 |
|
|
2016
Q1 | $3.56M | Buy |
31,915
+4,313
| +16% | +$546K | ﹤0.01% | 792 |
|
|
2015
Q4 | $4.32M | Buy |
27,602
+1,246
| +5% | +$181K | ﹤0.01% | 773 |
|
|
2015
Q3 | $3.46M | Buy |
26,356
+4,570
| +21% | +$733K | ﹤0.01% | 800 |
|
|
2015
Q2 | $3.79M | Buy |
21,786
+19,076
| +704% | +$3.43M | ﹤0.01% | 784 |
|
|
2015
Q1 | $467K | Buy |
+2,710
| New | +$413K | ﹤0.01% | 1302 |
|
Other funds holding UTHR
ACA
VPM
VCM
